We present a rare case of a gastric mixed adenoneuroendocrine tumor and review the related English literature. A 77-year-old Caucasian woman was admitted to our department with nausea, anorexia, weight loss, and anemia. Esophagogastroduodenoscopy showed a large (>7 cm) ulcerative mass in the greater curvature of the stomach. Biopsy showed the presence of an adenocarcinoma with moderate differentiation. The patient underwent D2 subtotal gastrectomy. Histopathological analysis revealed a diagnosis of mixed gastric adenoneuroendocrine carcinoma. The post-operative course was uneventful, and at the 6-month follow-up, the patient was alive without evidence of recurrence. Our review of the English literature suggested that such cases are most often reported from eastern countries. Multimodal treatment should be the aim for these patients because of the neuroendocrine component of the tumor. Case Report
Introduction
Collision tumors with adenocarcinoma and neuroendocrine elements are commonly diagnosed in the gastrointestinal tract. However, the occurrence of neuroendocrine carcinoma (NEC) in the gastrointestinal tract is rare, ranging from 1% in the esophagus, 0.2% in the colon, and 0.1% to 0.4% in the stomach. 1 Herein, we present a case of a mixed adenoneuroendocrine gastric tumor and review the English literature pertaining to such tumors.
Case Report
A 77-year-old Caucasian woman was admitted to our department with nausea, anorexia, weight loss, and anemia. The medical history of the patient did not include any significant prior illness.
The findings of physical examination were unremarkable. The We reviewed the English literature pertaining to gastric mixed tumors (Table 1) 6-20 and found that most such cases have been reported from eastern countries, probably because of the overall high incidence of gastric tumors in these countries. The 5-year survival rate is lower for these patients than for those with gastric adenocarcinoma. The neuroendocrine component may have a considerable impact on the prognosis. 21 Because of the mixed component of the tumor, treatment should focus on parts of the tumor with the more Fig. 2 . Immunoreactivity of the mucosal and submucosal tumor cells for chromogranin (chromogranin, ×10). After radical surgical resection, a chemotherapy regimen consisting of cisplatin, doxorubicin, and vincristine is highly recommended.
Mixed adenoneuroendocrine tumors are rare, but they are now well classified. Multimodal treatment should be the aim for these patients because of the neuroendocrine component of the tumor.
